Alterity Therapeutics Ltd ADR (ATHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 0 | 0 | 0 | 0 | 3,367 |
| Gross Profit | N/A | N/A | N/A | N/A | 3,367 |
| Operating Expenses | 12,978 | 15,182 | 11,680 | 12,724 | 14,537 |
| Operating Income | -12,978 | -15,182 | -11,680 | -12,724 | -11,170 |
| Other Income | 5,155 | 2,671 | 2,456 | 3,454 | -269 |
| Pre-tax Income | -7,823 | -12,511 | -9,224 | -9,270 | -11,439 |
| Income Tax | 44 | 30 | 70 | 51 | N/A |
| Net Income Continuous | -7,867 | -12,541 | -9,295 | -9,321 | -11,439 |
| Net Income | $-7,867 | $-12,541 | $-9,295 | $-9,321 | $-11,439 |
| EPS Basic Total Ops | -0.74 | -2.05 | -2.30 | -2.31 | -4.04 |
| EPS Basic Continuous Ops | -0.74 | -2.06 | -2.30 | -2.32 | -4.04 |
| EPS Diluted Total Ops | -0.74 | -2.05 | -2.30 | -2.31 | -4.04 |
| EPS Diluted Continuous Ops | -0.74 | -2.06 | -2.30 | -2.32 | -4.04 |
| EPS Diluted Before Non-Recurring Items | -0.74 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-12,888 | $-15,086 | $-11,611 | $-12,685 | $-11,114 |